QRCS monitors phase 1 of the vaccination campaign in Syria

Qatar Red Crescent Society (QRCS) has commenced its monitoring of phase 1 of the World Health Organization’s (WHO) COVID-19 vaccination campaign in northern Syria, as part of the COVID-19 Vaccines Global Access (COVAX), a global initiative, which aims at equitable access to COVID-19 vaccines. This particular program is done under the neutral vaccination monitoring program in Syria.

During the initial days of this month, the Syria Vaccination Team initiated the campaign in Aleppo countryside, Idlib province, and its countryside as well. The phase 1 of the campaign involved providing the first dose of the AstraZeneca COVID-19 vaccine to health and humanitarian professionals in the northern part of the country. This phase that lasts for 25 days, targets to cover 53,000 health along with the relief workers in 82 facilities.

As a neutral organisation, QRCS aims to ensure that it goes in line with international vaccination standards. In joint collaboration with the WHO, 30 well-trained field inspectors are deployed across the designated areas to enforce the campaign’s quality indicators, verify the readiness of vaccination centres, supervise the validity of injections and personnel performance, and ensure that everyone across the region receives this vaccine. QRCS has also immense experience in monitoring vaccination campaigns against infectious diseases in and around the world.

Qatar Red Crescent Society Vaccination Campaign Syria COVAX Neutral Vaccination Monitoring Program Qatar News Qatar Day Qatar